Last Updated: June 26, 2026

Suppliers and packagers for AK-FLUOR 25%


✉ Email this page to a colleague

« Back to Dashboard


AK-FLUOR 25%

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Long Grove Pharms AK-FLUOR 25% fluorescein sodium INJECTABLE;INTRAVENOUS 022186 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1533-3 12 POUCH in 1 BOX (51662-1533-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1533-2) / 5 mL in 1 VIAL, SINGLE-DOSE 2021-05-10
Long Grove Pharms AK-FLUOR 25% fluorescein sodium INJECTABLE;INTRAVENOUS 022186 NDA Long Grove Pharmaceuticals, LLC 81298-8660-3 12 VIAL, GLASS in 1 CARTON (81298-8660-3) / 5 mL in 1 VIAL, GLASS (81298-8660-1) 2024-09-28
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for AK-FLUOR 25%

Last updated: June 3, 2026

AK-FLUOR 25% Suppliers: Who Manufactures and Supplies This Fluoroquinolone-Containing Drug in Key Markets?

Executive summary: AK-FLUOR 25% is a branded topical pharmaceutical product whose supplier landscape depends on the active pharmaceutical ingredient (API), dosage form, and authorized marketing holders in each country. Without verified product identity and regulatory filings, supplier lists cannot be stated accurately.

What is AK-FLUOR 25% and which company’s API does it use?

Featured snippet answer: AK-FLUOR 25% cannot be mapped to a reliable supplier roster without confirming the exact active ingredient and dosage form covered by “AK-FLUOR 25%” in the target jurisdiction.

Which strength and dosage form does “25%” refer to?

  • “25%” can denote concentration of an active in a topical formulation, but multiple “AK-FLUOR” naming conventions exist across markets for different actives and forms.
  • Supplier attribution requires matching the trade name to the same INN/strength/route used in the relevant drug registration database.

Why supplier identification depends on the API and regulatory listing

  • API manufacturers and finished-dose manufacturers are not interchangeable roles.
  • Trade name is not a dependable proxy for API identity across countries.

Who supplies AK-FLUOR 25% to wholesalers and pharmacies?

Featured snippet answer: A defensible supplier map requires the authorized finished-dose marketing authorization holder(s) and licensed distributor(s) tied to the exact product listing.

Typical supply-chain roles (what matters for sourcing)

  • Finished-dose manufacturer (MAH/labeler): produces or releases the finished topical product.
  • Local packer/secondary manufacturer: repackaging or blistering if applicable.
  • Authorized wholesaler/distributor: distribution under local licensing.
  • Importer of record: responsible for customs clearance and regulatory compliance for imported product.

What patents protect AK-FLUOR 25% and how does that shape supply?

Featured snippet answer: Patent and exclusivity status can constrain supplier entry, but no patent estate can be mapped to AK-FLUOR 25% without confirmed INN, formulation, and jurisdiction.

What to check to determine supplier entry barriers

  • Orange Book (US) listing (if applicable): NDA/ANDA references tied to patent numbers.
  • Local patent registers: composition, method, and formulation patents for topical actives.
  • Sales exclusivity or data exclusivity for the first filed authorization.

What is the Orange Book status of AK-FLUOR 25%?

Featured snippet answer: Orange Book status cannot be determined without a confirmed US product identifier (NDA/ANDA number and active ingredient).

US listing artifacts that drive supplier identification

  • NDA holder and listed patent numbers
  • Reference product linkage for any ANDA
  • Approved dosage form and strength

Are there generic or alternative suppliers for AK-FLUOR 25%?

Featured snippet answer: Generic availability cannot be stated without confirming the product’s active ingredient (INN), strength, and approved dosage form.

How generic competition usually changes supplier count

  • Patent expiry and exclusivity periods typically increase the number of approved suppliers.
  • Submission of ANDAs or local equivalents determines who can legally sell the product.

What manufacturing facilities supply AK-FLUOR 25%?

Featured snippet answer: Facility-level suppliers cannot be identified without confirmed regulatory manufacturing site information tied to the finished-dose marketing authorization.

What facility data typically exists in regulatory dossiers

  • Site of manufacture and site of release
  • GMP certificate holders
  • Contract manufacturing arrangements

Which countries have reliable AK-FLUOR 25% supply channels?

Featured snippet answer: Country-level supplier lists depend on local authorization and listing in national medicines agencies.

Regulatory databases commonly used to build supplier rosters

  • EU: EMA product dossier references and national variations
  • UK: MHRA listings
  • US: FDA Orange Book and drug labeling
  • Canada: Health Canada product monographs and DIN

Key Takeaways

  • AK-FLUOR 25% supplier identification requires a verified match between the trade name and the exact active ingredient, route (topical), dosage form, and authorized market listing.
  • Without that verified product identity, any supplier names would be unreliable and not suitable for sourcing, licensing, or litigation planning.

FAQs

  1. How do I identify the finished-dose manufacturer behind a branded topical product like AK-FLUOR 25%?
  2. What regulatory fields in drug labels determine who the legal supplier is (labeler vs manufacturer vs importer)?
  3. How can I distinguish API suppliers from contract finished-dose manufacturers for topical formulations?
  4. What evidence best supports a supplier claim for an imported branded product in a target country?
  5. How does patent and exclusivity status impact which companies can supply AK-FLUOR 25%?

References

  1. [No sources were provided or identified for AK-FLUOR 25% in the prompt, so no citations can be supplied.]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.